Former pharmaceutical executive leading change eight months into his tenure; seeks focus and outreach to young members Jacobovitz Shal Jacobovitz didn't have "become an association leader" on his career checklist. Yet there he is, eight months into his new job as CEO of the Washington, D.C.-based, $76 million-revenue American College of Cardiology. "I never would have thought this in a million years," he told CEO Update. So the Canada-born Jacobovitz—who was then in San Francisco as president of the U.S. division of Switzerland's Actelion Pharmaceuticals—thought there was a mix-up when he got a call from Korn/Ferry International. "I told them they had the wrong… Read More